We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sorting Device Designed to Catch Rambling Cancer Cells

By LabMedica International staff writers
Posted on 25 Jun 2012
Two US engineers reported that they have found a simple way to use gravity or simple forces to sort microscopic particles and bits of biologic substances, including circulating tumor cells (CTCs).

In the May 25, 2012, online issue of the journal Physical Review Letters, Dr. More...
German Drazer, an assistant professor of chemical and biomolecular engineering at Johns Hopkins University (Baltimore, MD, USA) and his doctoral student Jorge A. Bernate reported that they have developed a microfluidic device that can sort particles, cells or other tiny matter by physical means. By moving a liquid over a series of micrometer-scale high diagonal ramps the device causes microscopic material to separate into distinct categories, based on weight, size, or other factors, according to the scientists.

The process described in the journal article could be used to generate a medical diagnostic tool, according to the researchers. “The ultimate goal is to develop a simple device that can be used in routine checkups by healthcare providers,” said Mr. Bernate, who is lead author on the study. “It could be used to detect the handful of circulating tumor cells that have managed to survive among billions of normal blood cells. This could save millions of lives.”

Ideally, these cancer cells in the bloodstream could be detected and targeted for treatment before they have had a chance to metastasize, or spread cancer elsewhere. Detection at early stages of cancer is critical for successful treatment. Mr. Bernate explained that inside the microfluidic device, particles and cells that have been suspended in liquid flow along a “highway” that has speed-bump-like obstacles positioned diagonally, instead of perpendicular to, the path. The speed bumps differ in height, depending on the application.

“As different particles are driven over these diagonal speed bumps, heavier ones have a harder time getting over than the lighter ones,” Mr. Bernate stated. When the particles cannot get over the ramp, they begin to change course and travel diagonally along the length of the obstacle. As the process continues, particles end up fanning out in different directions. After the particles cross this section of the ‘highway,’ they end up in different ‘lanes’ and can take different ‘exits,’ which allows for their continuous separation.”
Gravity is not the only way to slow down and sort particles as they attempt to move the speed bumps. “Particles with an electrical charge or that are magnetic may also find it hard to go up over the obstacles in the presence of an electric or magnetic field,” Mr. Bernate said. For instance, cancer cells could be “weighted down” with magnetic beads and then sorted in a device with a magnetic field.

The ability to sort and separate things at the micro- and nano-scale is significant in many industries, ranging from solar power to bio-security. However, Mr. Bernate reported that a medical application is expected to have the most potential for immediate use. His doctoral adviser, Dr. Drazer, noted that, the research ultimately should lead to the development of a device that can easily sort whole blood into its components. A provisional patent has been filed for this device.

Related Links:

Johns Hopkins University



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.